Immucell (ICCC) Net Shares Issued and Repurchased (2018 - 2025)

Immucell (ICCC) has reported Net Shares Issued and Repurchased for 8 consecutive years, with $288260.0 the latest figure, recorded in Q4 2025.

• For the quarter ending Q4 2025, Net Shares Issued and Repurchased rose 235.19% year-over-year to $288260.0; the trailing twelve-month figure through Dec 2025 stood at $288260.0 (up 235.19% YoY), and the FY2025 full-year result was $288260.0, up 235.19% from the prior year.
• Net Shares Issued and Repurchased climbed to $288260.0 in Q4 2025 per ICCC's latest filing, from $75983.0 in the prior quarter.
• Across five years, Net Shares Issued and Repurchased topped out at $288260.0 in Q4 2025 and bottomed at $2000.0 in Q1 2024.
• Historically, Net Shares Issued and Repurchased has averaged $97340.3 across 5 years, with a median of $86000.0 in 2021.
• The sharpest annual moves came in 2022 and 2024: Net Shares Issued and Repurchased surged 1128.57% in 2022, then plunged 97.62% in 2024.
• Over 5 years, Net Shares Issued and Repurchased stood at $86000.0 in 2021, then soared by 144.77% to $210500.0 in 2022, then slumped by 42.04% to $122000.0 in 2023, then retreated by 29.51% to $86000.0 in 2024, then surged by 235.19% to $288260.0 in 2025.
• According to Business Quant data, Net Shares Issued and Repurchased over the past three periods registered $288260.0, $75983.0, and $23000.0 for Q4 2025, Q3 2025, and Q1 2025 respectively.